Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.
about
Impaired neuropathic pain and preserved acute pain in rats overexpressing voltage-gated potassium channel subunit Kv1.2 in primary afferent neuronsBrain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptorNeuron-restrictive silencer factor-mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain.Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle.Nonviral retrograde gene transfer of human hepatocyte growth factor improves neuropathic pain-related phenomena in rats.AAV provides an alternative for gene therapy of the peripheral sensory nervous system.Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture.Naloxone can act as an analgesic agent without measurable chronic side effects in mice with a mutant mu-opioid receptor expressed in different sites of pain pathway.Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats.Colon distention induces persistent visceral hypersensitivity by mechanotranscription of pain mediators in colonic smooth muscle cellsDevelopment of viral vectors for gene therapy for chronic paindsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm.Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain.Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic painViral vector-based gene transfer for treatment of chronic pain.Gene therapy applications for the treatment of neuropathic pain.From neuroanatomy to gene therapy: searching for new ways to manipulate the supraspinal endogenous pain modulatory system.A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons.Applications of gene therapy to the treatment of chronic pain.A human trial of HSV-mediated gene transfer for the treatment of chronic pain.Ca2+/calmodulin-dependent protein kinase II potentiates ATP responses by promoting trafficking of P2X receptors.Detection of the endogenous mu opioid receptor (mopr) in brainAnalgesic tolerance of opioid agonists in mutant mu-opioid receptors expressed in sensory neurons following intrathecal plasmid gene delivery.A common single nucleotide polymorphism A118G of the μ opioid receptor alters its N-glycosylation and protein stability.Gene therapy: a potential approach for cancer pain.Generation and validation of novel adeno-associated viral vectors for the analysis of Ca2+ homeostasis in motor neurons.Pain research update from a genetic point of view.Gene Therapy for Pain: A PerspectiveRetrograde viral vector-mediated inhibition of pontospinal noradrenergic neurons causes hyperalgesia in rats.Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal.Transgene expression and effective gene silencing in vagal afferent neurons in vivo using recombinant adeno-associated virus vectors.Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats.A-Type K Channels in Dorsal Root Ganglion Neurons: Diversity, Function, and Dysfunction
P2860
Q28568519-023A7153-216E-4130-9050-172DA34954A7Q33589637-061D9CD7-D56C-418F-A797-A25E334DAFD0Q33595867-B7AC192E-6ED8-431A-8B19-ADDF45247F48Q33691877-BABF37FE-594F-435B-B705-4F538BC1E0C0Q33712995-D99AA5DF-072A-480C-9DE9-549334BBC7DAQ33822179-41333521-FFBF-49FB-B132-280A1656E5DCQ33822237-DAB46DC1-0BAB-4611-8B76-4DD0B05DB970Q33975660-478F182A-1631-4717-9EC5-92D43373404CQ34191032-A5F25D5A-E92C-49BA-95E0-69F3E241DFBAQ34684229-9621AEA7-EB7B-455F-BF8A-861C68297009Q35138530-F96E32A1-3037-4748-9CEB-F9076105FC2CQ35430864-06A9A8FA-DC25-4343-803A-1C6E99E9EA0DQ36289075-204CA56B-DBE0-477A-83DC-C4F8496E2BD5Q36458975-6B051972-C9D3-4F68-B1BD-6954B90214C0Q36512520-BBB66934-F67A-4BD6-8DCF-EC7CD8FF335AQ36787828-CB070978-C622-4BFA-B658-38303C1C9DA5Q36817045-63C868C0-47DB-4C86-9D2D-B4112B1C88CBQ36861028-D12C3E87-D542-475C-A0D8-C3221A04ABB1Q37092389-7CCC827A-3293-4D18-A6C0-0A1B0A534932Q37108334-F49710CB-18EC-4DAD-8005-B9B8BB8F1CECQ37195741-0FDF5D49-1E19-4CFF-9551-324AA33E930BQ37416353-68D68925-97AD-4B3F-ACE9-640926E6AE5FQ37501934-07314088-8BA9-4394-B86E-FC7F9C8DD333Q37532600-997E92F8-3590-42DE-887A-53E2FE1F5806Q37582266-9C8179CE-F18E-4B05-9917-9CA6A84DA5A3Q38745962-3862E870-AA02-45A7-805F-C13BAFEF397AQ40106935-0020875C-DB31-48C0-9998-1BBEA009ADE1Q40259080-AAE87658-2BC4-4D5F-B155-F7579887208AQ41841809-6AED3554-302E-450B-A144-116F6CAE0CBDQ42117065-D843B1B5-09EA-4495-9873-6CAA30F97A83Q44350051-CAC6E13C-A5F4-466D-834A-2EF5FFF4D293Q45373500-B227FC5A-D3E2-4715-999A-1BCB8A8FFB26Q55428388-5F0D98B5-1CC0-42DF-87F9-5EBDDDE2A19EQ58799022-EE59746E-F407-47F4-B56B-0AD39F0BB3DA
P2860
Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Adeno-associated viral transfe ...... crease opioid antinociception.
@ast
Adeno-associated viral transfe ...... crease opioid antinociception.
@en
type
label
Adeno-associated viral transfe ...... crease opioid antinociception.
@ast
Adeno-associated viral transfe ...... crease opioid antinociception.
@en
prefLabel
Adeno-associated viral transfe ...... crease opioid antinociception.
@ast
Adeno-associated viral transfe ...... crease opioid antinociception.
@en
P2093
P2860
P356
P1476
Adeno-associated viral transfe ...... crease opioid antinociception.
@en
P2093
P2860
P304
P356
10.1073/PNAS.0930324100
P407
P577
2003-04-28T00:00:00Z